No. | Age | Gender | Mutant gene | Mutation site | Gene Mutation Status | Mutation Type | Method | Histological diagnosis | TNM | Stage (AJCC) |
19-RLN0201 | 35 | M | EGFR | 19-del | Mutant typ | DEL | PCR | Adenocarcinoma | T1N2M0 | IIIA |
19-RLN0202 | 60 | F | EGFR | 19-del | Mutant typ | DEL | PCR | Adenocarcinoma | T4N2M1 | IV |
19-RLN0203 | 64 | F | EGFR | 19-del | Mutant typ | DEL | PCR | Adenocarcinoma | T1N0M0 | IA |
19-RLN0204 | 56 | F | EGFR | 19-del | Mutant typ | DEL | PCR | Adenocarcinoma | T1N0M0 | IA |
19-RLN0205 | 49 | M | EGFR | 19-del | Mutant typ | DEL | PCR | Adenocarcinoma | T1N0M0 | IA |
19-RLN0206 | 58 | F | EGFR | 19-del | Mutant typ | DEL | PCR | Adenocarcinoma | T4N2M1 | IV |
19-RLN0207 | 66 | F | EGFR | 19-del | Mutant typ | DEL | PCR | Adenocarcinoma | T1N0M0 | IA |
19-RLN0208 | 61 | F | EGFR | 19-del | Mutant typ | DEL | PCR | Adenocarcinoma | T1N0M0 | IA |
19-RLN0209 | 55 | F | EGFR | 19-del | Mutant typ | DEL | PCR | Adenocarcinoma | T1N0M0 | IA |
19-RLN0210 | 56 | F | EGFR | 19-del | Mutant typ | DEL | PCR | Adenocarcinoma in si | T1N0M0 | IA |
19-RLN0211 | 52 | F | EGFR | 19-del | Mutant typ | DEL | PCR | Adenocarcinoma | T1N0M0 | IA |
19-RLN0212 | 72 | F | EGFR | 19-del | Mutant typ | DEL | PCR | Adenocarcinoma | T1N0M0 | IA |
19-RLN0213 | 59 | F | EGFR | 19-del | Mutant typ | DEL | PCR | Adenocarcinoma | T2N3M0 | IIIB |
19-RLN0214 | 53 | F | EGFR | 19-del | Mutant typ | DEL | PCR | Adenocarcinoma | T1N0M0 | IA |
19-RLN0215 | 60 | F | EGFR | 19-del | Mutant typ | DEL | PCR | Adenocarcinoma | T1N0M0 | IA |
19-RLN0216 | 50 | F | EGFR | 19-del | Mutant typ | DEL | PCR | Adenocarcinoma | T1N0M0 | IA |
19-RLN0217 | 65 | M | EGFR | 19-del | Mutant typ | DEL | PCR | Adenocarcinoma | T2N2M0 | IIIA |
19-RLN0218 | 55 | F | EGFR | 19-del | Mutant typ | DEL | PCR | Mucinous / non mucin | T2N0M0 | IIA |
19-RLN0219 | 71 | M | EGFR | 19-del | Mutant typ | DEL | PCR | Adenocarcinoma | T4N1M1 | IV |
19-RLN0220 | 63 | F | EGFR | 19-del | Mutant typ | DEL | PCR | Adenocarcinoma | T3N2M1 | IV |
L-RLN0201 | 53 | M | EGFR | L858R | Mutant typ | Mutation | PCR | Adenocarcinoma | T2N0M0 | IIA |
L-RLN0202 | 47 | M | EGFR | L858R | Mutant typ | Mutation | PCR | Adenocarcinoma | T1N0M0 | IA |
L-RLN0203 | 65 | F | EGFR | L858R | Mutant typ | Mutation | PCR | Adenocarcinoma | T3N2M1 | IV |
L-RLN0204 | 65 | M | EGFR | L858R | Mutant typ | Mutation | PCR | Adenocarcinoma | T1N0M0 | IA |
L-RLN0205 | 65 | F | EGFR | L858R | Mutant typ | Mutation | PCR | Adenocarcinoma | T1N0M0 | IA |
L-RLN0206 | 64 | M | EGFR | L858R | Mutant typ | Mutation | PCR | Adenocarcinoma | T1N0M0 | IA |
L-RLN0207 | 76 | F | EGFR | L858R | Mutant typ | Mutation | PCR | Adenocarcinoma | T1N0M0 | IA |
L-RLN0208 | 53 | F | EGFR | L858R | Mutant typ | Mutation | PCR | Adenocarcinoma | T1N0M0 | IA |
L-RLN0209 | 52 | F | EGFR | L858R | Mutant typ | Mutation | PCR | Adenocarcinoma | T1N0M0 | IA |
L-RLN0210 | 69 | M | EGFR | L858R | Mutant typ | Mutation | PCR | Adenocarcinoma | T4N1M0 | IIIA |
L-RLN0211 | 63 | M | EGFR | L858R | Mutant typ | Mutation | PCR | Adenocarcinoma | T1N0M0 | IA |
L-RLN0212 | 65 | F | EGFR | L858R | Mutant typ | Mutation | PCR | Adenocarcinoma | T2N2M0 | IIIA |
L-RLN0213 | 53 | F | EGFR | L858R | Mutant typ | Mutation | PCR | Adenocarcinoma in si | T1N0M0 | IA |
L-RLN0214 | 56 | F | EGFR | L858R | Mutant typ | Mutation | PCR | Adenocarcinoma | T4N1M1 | IV |
L-RLN0215 | 41 | M | EGFR | L858R | Mutant typ | Mutation | PCR | Adenocarcinoma in si | T1N0M0 | IA |
L-RLN0216 | 44 | F | EGFR | L858R | Mutant typ | Mutation | PCR | Adenocarcinoma in si | T1N0M0 | IA |
L-RLN0217 | 69 | F | EGFR | L858R | Mutant typ | Mutation | PCR | Adenocarcinoma | T2N0M0 | IIA |
L-RLN0218 | 52 | F | EGFR | L858R | Mutant typ | Mutation | PCR | Adenocarcinoma | T1N0M0 | IA |
L-RLN0219 | 62 | F | EGFR | L858R | Mutant typ | Mutation | PCR | Adenocarcinoma | T3N1M0 | IIIA |
L-RLN0220 | 67 | F | EGFR | L858R | Mutant typ | Mutation | PCR | Adenocarcinoma | T1N0M0 | IA |
|